Adc Therapeutics Sa Stock Analysis

ADC Stock Analysis Notes

About 21.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.74. ADC Therapeutics recorded a loss per share of 2.3. The entity had not issued any dividends in recent years. ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland. ADC Therapeutics operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 312 people. For more info on ADC Therapeutics SA please contact Christopher Martin at 41 21 653 02 00 or go to https://www.adctherapeutics.com.

ADC Therapeutics Investment Alerts

ADC Therapeutics Upcoming and Recent Events

ADC Largest EPS Surprises

View All Earnings Estimates

ADC Stock Institutional Investors

Note, although ADC Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ADC Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 199.18 M.

ADC Profitablity

The company has Profit Margin (PM) of (3.0) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.93) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.93.

Management Efficiency

ADC Therapeutics has return on total asset (ROA) of (0.2117) % which means that it has lost $0.2117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.0553) %, meaning that it created substantial loss on money invested by shareholders. ADC Therapeutics' management efficiency ratios could be used to measure how well ADC Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 1.70 in 2024, whereas Return On Tangible Assets are likely to drop (0.71) in 2024. At this time, ADC Therapeutics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 457.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 48.6 M in 2024.

Technical Drivers

As of the 22nd of November, ADC Therapeutics owns the market risk adjusted performance of (0.16), and Variance of 20.85. ADC Therapeutics SA technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.

ADC Therapeutics Price Movement Analysis

ADC Therapeutics Insider Trading Activities

ADC Therapeutics Outstanding Bonds

ADC Therapeutics Predictive Daily Indicators

ADC Therapeutics Forecast Models

ADC Therapeutics' time-series forecasting models are one of many ADC Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ADC Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ADC Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ADC shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ADC Therapeutics. By using and applying ADC Stock analysis, traders can create a robust methodology for identifying ADC entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ADC analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ADC analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ADC Therapeutics SA stock analysis indicators help investors evaluate how ADC Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ADC Therapeutics shares will generate the highest return on investment. By understating and applying ADC Therapeutics stock analysis, traders can identify ADC Therapeutics position entry and exit signals to maximize returns.

When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.